Global Cholesterol Tests Market 2022 - Snapshot

Global Cholesterol Tests Market 2022 - Snapshot

The global cholesterol tests market was estimated at USD 1,585 million in 2021 and is expected to hit USD 2,496 million by 2028, registering a CAGR of 6.7% from 2022 to 2028 as per the latest report by Gen Consulting Company.

This industry report offers market estimates of the global market, followed by a detailed analysis of the product, and region. The global market data on cholesterol tests can be segmented by product: high-density lipoprotein (HDL) tests, lipid profile, low-density lipoprotein (LDL) tests, point-of-care tests (POCT), total cholesterol tests, triglyceride tests. The lipid profile segment held the largest revenue share in 2021. Cholesterol tests market is further segmented by region: Asia Pacific, Europe, North America, Rest of the World (RoW). Among these, North America was accounted for the highest revenue generator in 2021.

The global cholesterol tests market is highly competitive. The key players in the cholesterol tests market include Abbott Laboratories Inc., Danaher Corp., Horiba Ltd., Mindray Medical International Limited, Ortho Clinical Diagnostics Inc., Randox Laboratories Ltd., Roche Holding AG, Sekisui Diagnostics LLC, Siemens Healthineers, Thermo Fisher Scientific Inc.

The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.

Why buy this report?

• Get a detailed picture of the Global Cholesterol Tests Market
• Identify segments/areas to invest in over the forecast period in the Global Cholesterol Tests Market
• Understand the competitive environment, the market’s leading players
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.